Science Explorer Back to mapMap
Discussion
Researcher · The University of Texas MD Anderson Cancer Center · United States

Mark Routbort

Mark Routbort publishes mostly in Molecular Biology, Oncology and Hematology, on topics such as Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#2,130,006
of 7,710,434 ranked researchers
Rank in United States
#641,833
of 1,627,098
Works
27
Citations
988
Citations per work
36.6
h-index
10
i10-index 11Top 76% in Molecular Biology
Mark Routbort

What does Mark Routbort research?

Mark Routbort's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (30%).

Health Sciences: 11 works · 40.3% of their workMedicine: 11 works · 40.3% of their workOncology: 4 works · 13.9% of their workHematology: 3 works · 12.5% of their workPulmonary and Respiratory Medicine: 2 works · 8.3% of their workGenetics: 2 works · 5.6% of their workLife Sciences: 8 works · 30.5% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 30.5% of their workMolecular Biology: 6 works · 20.8% of their workCancer Research: 3 works · 9.7% of their workEverything else: 8 works · 29.2% of their workTHEIR WORKMark Routbort27works
Life Sciences30%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1140.3%
    1. Biochemistry, Genetics and Molecular Biology830.5%
  3. Everything else829.2%
  1. 1Molecular Biology21% of their works
  2. 2Oncology14% of their works
  3. 3Hematology12% of their works
  4. 4Cancer Research10% of their works
  5. 5Pulmonary and Respiratory Medicine8% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Mark Routbort's research?

The keywords of their largest research topics: Targeted Therapy, Acute Myeloid Leukemia, AML, Cancer Genomics, Mutational Signatures, ALK Inhibitors, EGFR Mutations and Colorectal Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Targeted Therapy112 topics
  2. AML81 topic
  3. Acute Myeloid Leukemia81 topic
  4. Cancer Genomics71 topic
  5. Mutational Signatures71 topic
  6. ALK Inhibitors41 topic
  7. EGFR Mutations41 topic
  8. Colorectal Cancer31 topic
  9. JAK2 Mutation31 topic
  10. Myelofibrosis31 topic
  11. Screening31 topic
  12. BRAF gene21 topic
  13. MAP Kinase21 topic
  14. Signaling21 topic
  15. Single-Cell21 topic
  16. Transcriptomics21 topic
  17. mTOR21 topic

Where does Mark Routbort work?

Mark Routbort's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.

How many publications and citations does Mark Routbort have?

OpenAlex counts 27 works and 988 citations for Mark Routbort, an h-index of 10, ranking #2,130,006 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark Routbort. Posts are plain text and can be reported.